Driver Mutations and Prognosis in Primary Myelofibrosis: Mayo-Careggi MPN Alliance Study of 1,095 Patients

American Journal of Hematology - United States
doi 10.1002/ajh.24978
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

JAK2 Exon 12 Mutated Polycythemia Vera: Mayo-Careggi MPN Alliance Study of 33 Consecutive Cases and Comparison With JAK2 V617F Mutated Disease

American Journal of Hematology
Hematology
2018English

Prognosis of Primary Myelofibrosis in the Genomic Era

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

SF3B1 Mutations in Primary Myelofibrosis: Clinical, Histopathology and Genetic Correlates Among 155 Patients

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Primary Myelofibrosis Is Not Primary Anymore Since the Discovery of MPL515 and CALR Mutations as Driver Causes of Mono-Linear Megakaryocytic and Dual Megakaryocytic Granulocytic Myeloproliferation and Secondary Myelofibrosis

2019English

Driver Mutation‐Specific Clinical and Genomic Correlates Differ Between Primary and Secondary Myelofibrosis

American Journal of Hematology
Hematology
2019English

Primary Tumor Driver Mutations Also Drive Metastases

Cancer Discovery
Oncology
2018English

New Сytogenetic Approaches in Patients With Primary Myelofibrosis

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2016English

Driver Mutations in Melanoma

Libri Oncologici
Oncology
2018English

SRSF2 Mutations in Primary Myelofibrosis: Significant Clustering With IDH Mutations and Independent Association With Inferior Overall and Leukemia-Free Survival

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy